Week In Review: Everest In-Licenses An ADC From Immunomedics In $835 Million Agreement, A China Record For A Single Asset
Published on: Sunday 05 May 2019
So far, it has earned returns of between 200% and 500% on five closed investments. Digital China Health Technologies participated in a $17.1 million extension of a Congenica Series B funding that ...
